During the past decade, SMZ-Ost Donauspital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SMZ-Ost Donauspital" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Allergan" with 1 trials sponsored, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials sponsored, "EBMT Solid Tumors Working Party" with 1 trials sponsored and "International Biomedical Systems S.p.A." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SMZ-Ost Donauspital" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "SMZ-Ost Donauspital" with 3 trials as a collaborator, "Medical University Innsbruck" with 2 trials as a collaborator, "Brothers of Saint John of God Eisenstadt" with 1 trials as a collaborator and "CSC Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "SMZ-Ost Donauspital" are "Atopic Dermatitis" (4 trials), "COVID-19" (1 trials), "Covid19" (1 trials), "Diffuse Large B-Cell Lymphoma (DLBCL)" (1 trials) and "Follicular NHL Grade 3b" (1 trials). Many other conditions were trialed in "SMZ-Ost Donauspital" in a lesser frequency.

Most popular intervention types in "SMZ-Ost Donauspital" are "Drug" (8 trials), "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Baricitinib" (3 trials), "AGN-214868" (1 trials), "AGN-214868 Placebo (Vehicle)" (1 trials) and "Asunercept 100mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "SMZ-Ost Donauspital" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "SMZ-Ost Donauspital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in SMZ-Ost Donauspital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in SMZ-Ost Donauspital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".